BackOpiant Pharmaceuticals Overview

Opiant Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for OPNT.

Quarterly SG&A Expenses

$5.67M
↑ 27.74% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$24.39M
↑ 48.82% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin